A Food and Drug Administration official involved in scrutinizing the safety of antidepressants, COVID-19 vaccines and other ...

The data were presented at the American Urological Association (AUA) 2026 Annual Meeting. ・Candel plans to submit a Biologics ...

Exelixis (EXEL 1.92%) has been a solid stock to own over the past five years, with its shares climbing 101%, slightly beating ...

The agency approved the antibody-drug conjugate for treating HER2-positive neoadjuvant and adjuvant breast cancer alongside an IHC and an ISH test for identifying best responders.

A breakthrough study found that a hallucinogenic compound best known for altering the mind has surprising rejuvenating ...

In the IMvigor011 trial, ctDNA-guided adjuvant atezolizumab reduced the risk of disease recurrence or death by 36% and the ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...

Natera said the Food and Drug Administration approved its Signatera CDx as a test for bladder cancer. The drug can be used as a companion diagnostic with adjuvant atezolizumab to treat muscle-invasive ...

Researchers have long known that bacteria could potentially be used to deliver therapeutic drugs inside the human body. However, safely and successfully carrying out such a feat in humans has been a ...

Weight gain in adulthood may increase a person's cancer risk by as much as fivefold, according to a Swedish study. (The Guardian) An updated review of data for nearly 800,000 participants in prostate ...

MORE FOR YOU Better yet, it’s the “beginning” as Jaffee says, “not the end.” With Revolution having revealed something ...